# NALOXONE HCI

NDC: 51662-1242
Generic name: NALOXONE HCI
Labeler / Manufacturer: HF Acquisition Co. LLC, DBA Health First
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20180818

FDA application: ANDA070256

## Active ingredients

- NALOXONE HYDROCHLORIDE: .4 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51662-1242"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51662-1242
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=73c1bad3-6ac3-8682-e053-2a91aa0a176a